CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS SFr in Thousands	12 Months Ended
	Dec. 31, 2016 € / shares	Dec. 31, 2016 CHF (SFr)	Dec. 31, 2015 € / shares	Dec. 31, 2015 CHF (SFr)
Revenue
Research and development services		SFr 379		SFr 2,043
Grants		874		1,108
Total revenue		1,253		3,151
Expenses
Research and development		1,001		1,727
General and administrative		1,234		1,542
Bank fee		2		3
Depreciation		42		43
Impairment of in-process research and development		2,266		0
Directors' fees		20		20
Other		95		209
Total expenses		4,660		3,544
Operating Loss		(3,407)		(393)
Interest revenue		(3)		(3)
Interest expense		2,571		2,571
Loss before income tax (provision) benefit		(5,975)		(2,961)
Income tax (provision) benefit		11		(45)
Net loss		(5,964)		(3,006)
Other comprehensive income (loss) Foreign currency translation adjustment		0		57
Comprehensive loss		SFr (5,964)		SFr (2,949)
Basic and diluted loss per share | € / shares	€ (0.02)		€ (0.01)